1133 related articles for article (PubMed ID: 27581457)
1. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
[TBL] [Abstract][Full Text] [Related]
2. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats.
Brugnoli A; Pisanò CA; Morari M
Neurobiol Dis; 2020 Oct; 144():105044. PubMed ID: 32798726
[TBL] [Abstract][Full Text] [Related]
3. Striatal cholinergic interneurons regulate cognitive and affective dysfunction in partially dopamine-depleted mice.
Ztaou S; Lhost J; Watabe I; Torromino G; Amalric M
Eur J Neurosci; 2018 Nov; 48(9):2988-3004. PubMed ID: 30230645
[TBL] [Abstract][Full Text] [Related]
4. Cortical and nigral deafferentation and striatal cholinergic markers in the rat dorsal striatum: different effects on the expression of mRNAs encoding choline acetyltransferase and muscarinic m1 and m4 receptors.
Kayadjanian N; Schofield WN; Andren J; Sirinathsinghji DJ; Besson MJ
Eur J Neurosci; 1999 Oct; 11(10):3659-68. PubMed ID: 10564373
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic acetylcholine M
Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
[TBL] [Abstract][Full Text] [Related]
6. Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat.
Chambers NE; Meadows SM; Taylor A; Sheena E; Lanza K; Conti MM; Bishop C
Neuroscience; 2019 Jun; 409():180-194. PubMed ID: 31029732
[TBL] [Abstract][Full Text] [Related]
7. Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt
Hamann M; Plank J; Richter F; Bode C; Smiljanic S; Creed M; Nobrega JN; Richter A
Neuroscience; 2017 Aug; 357():84-98. PubMed ID: 28596119
[TBL] [Abstract][Full Text] [Related]
8. The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.
Tozzi A; de Iure A; Di Filippo M; Tantucci M; Costa C; Borsini F; Ghiglieri V; Giampà C; Fusco FR; Picconi B; Calabresi P
J Neurosci; 2011 Feb; 31(5):1850-62. PubMed ID: 21289195
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M
Moehle MS; Pancani T; Byun N; Yohn SE; Wilson GH; Dickerson JW; Remke DH; Xiang Z; Niswender CM; Wess J; Jones CK; Lindsley CW; Rook JM; Conn PJ
Neuron; 2017 Dec; 96(6):1358-1372.e4. PubMed ID: 29268098
[TBL] [Abstract][Full Text] [Related]
10. Roles of the M
Moehle MS; Conn PJ
Mov Disord; 2019 Aug; 34(8):1089-1099. PubMed ID: 31211471
[TBL] [Abstract][Full Text] [Related]
11. Neostriatal GABAergic Interneurons Mediate Cholinergic Inhibition of Spiny Projection Neurons.
Faust TW; Assous M; Tepper JM; Koós T
J Neurosci; 2016 Sep; 36(36):9505-11. PubMed ID: 27605623
[TBL] [Abstract][Full Text] [Related]
12. M
Lv X; Dickerson JW; Rook JM; Lindsley CW; Conn PJ; Xiang Z
Neuropharmacology; 2017 May; 118():209-222. PubMed ID: 28336323
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesias.
Bordia T; Perez XA
Eur J Neurosci; 2019 Mar; 49(6):859-868. PubMed ID: 29923650
[TBL] [Abstract][Full Text] [Related]
14. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL
Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876
[TBL] [Abstract][Full Text] [Related]
15. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
Bordia T; Zhang D; Perez XA; Quik M
Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
[TBL] [Abstract][Full Text] [Related]
16. Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.
Aldrin-Kirk P; Heuer A; Rylander Ottosson D; Davidsson M; Mattsson B; Björklund T
Neurobiol Dis; 2018 Jan; 109(Pt A):148-162. PubMed ID: 29037828
[TBL] [Abstract][Full Text] [Related]
17. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.
Threlfell S; Clements MA; Khodai T; Pienaar IS; Exley R; Wess J; Cragg SJ
J Neurosci; 2010 Mar; 30(9):3398-408. PubMed ID: 20203199
[TBL] [Abstract][Full Text] [Related]
18. M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses.
Pancani T; Bolarinwa C; Smith Y; Lindsley CW; Conn PJ; Xiang Z
ACS Chem Neurosci; 2014 Apr; 5(4):318-24. PubMed ID: 24528004
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching.
McCool MF; Patel S; Talati R; Ragozzino ME
Neurobiol Learn Mem; 2008 Feb; 89(2):114-24. PubMed ID: 17709264
[TBL] [Abstract][Full Text] [Related]
20. Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias.
Bordia T; Perez XA; Heiss J; Zhang D; Quik M
Neurobiol Dis; 2016 Jul; 91():47-58. PubMed ID: 26921469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
